Evaluation of the effect of chamomile(matricaria chamomilla) extract on severity of anxiety before root canal therapy in anxious patient

Determining the prodrug effect of chamomile extract (Matarcaria camomila) on the severity of anxiety before endodontic treatment in anxious patients referred to the endodontic department of Isfahan Dental School

A double-blind randomized controlled clinical trial Sample size 64 people, simple randomization with random number table

After explaining the research process to the patient and completing the consent, the patient completes the Modified Dental Anxiety Questionnaire (MDAS). If the score is 11 or higher, the patient is anxious. Then, if the patient is in the control group, consumes 130ml of ordinary water and if the patient is in the intervention group, consumes 30oral drops of chamomile extract in 100 ml of ordinary water. After 60minutes, the anxiety questionnaire is completed again by patients in both groups

Samples of patients referred to the endodontic department of Isfahan Dental School are selected and randomly divided into two categories of intervention and control. Inclusion criteria: The patient is anxious, be mentally healthy and have the ability to fill out the questionnaire, have not used sedatives, the patient has no history of allergies to chamomile, the patient does not have asthma The patient should not take warfarin

In the control group, the patient consumes 130ml of normal water in a disposable glass with a door whose contents are not visible and in the intervention group, according to the instructions of the manufacturer, the patient takes 30oral drops of chamomile extract produced by Sina Faravar Pharmaceutical Company with the name of Kamazol and the standard mark and drug registration number is 8675081546681476 in 100ml of normal water in a disposable glass with a door whose contents are not visible.

Anxiety score

The sample size consists of 64 people who are randomly divided into two groups of 32 intervention and 32 control using the randomization block method. Using the site www.sealedenvelope.com and considering the 8 blocks, patients are divided.

In this study, participants and the physician treating the patient are kept blind because disposable cups with a door that is not visible inside are used and are all coded for consumption in the control and intervention groups. Depending on which group the patient number belongs to, In the control group, the patient consumes 130 ml of normal water in a disposable glass with a door whose contents are not visible and in the intervention group, according to the instructions of the manufacturer, the patient takes 30 oral drops of chamomile extract produced by Sina Faravar Pharmaceutical Company with the name of Kamazol and the standard mark and drug registration number is 8675081546681476 in 100 ml of normal water in a disposable glass with a door whose contents are not visible. In order to eliminate the psychological effect of chamomile smell, the lids of all the glasses in both groups have been pre-soaked with 2 drops of chamomile extract.